Valuation : Illumina, Inc.

Market Cap 34.38B 29.68B 27.82B 25.4B 47.8B 3,279B 48.03B 330B 129B 1,658B 129B 126B 5,502B P/E 2026 *
43.6x
P/E 2027 * 36.9x
Enterprise Value 34.63B 29.89B 28.02B 25.59B 48.14B 3,302B 48.37B 332B 130B 1,670B 130B 127B 5,542B EV / Sales 2026 *
7.49x
EV / Sales 2027 * 6.85x
Free-Float
74.98%
Yield 2026 *
-
Yield 2027 * -
1 day-5.31%
1 week+1.10%
Current month+5.11%
1 month+13.79%
3 months+43.56%
6 months+60.34%
Current year+64.37%
1 week 212.37
Extreme 212.37
231.81
1 month 186.64
Extreme 186.64
231.81
Current year 112.65
Extreme 112.65
231.81
1 year 88
Extreme 88
231.81
3 years 68.7
Extreme 68.7
231.81
5 years 68.7
Extreme 68.7
471.1
10 years 68.7
Extreme 68.7
555.77
Manager TitleAgeSince
Chief Executive Officer 51 24/09/2023
Director of Finance/CFO 50 14/04/2024
Chief Tech/Sci/R&D Officer - 31/01/2026
Director TitleAgeSince
Director/Board Member 65 27/07/2016
Director/Board Member 66 31/12/2016
Director/Board Member 65 04/02/2019
Date Insider Type Main position Quantity % Market Cap.
21/08/26
Corvex Management LP
SellCompany -299,336 0.1978%
19/08/26 Other

Director

0 0%
18/08/26 Sell

Executive/Senior Manager

-1,033 0.0007%
Change 5-day change 1-year change 3-year change Capi.($)
-5.31%+1.10%+116.59%+36.38% 34.38B
-1.35%-0.86%+27.46%+14.88% 233B
+0.18%+0.07%+5.40%-15.44% 152B
+1.51%-0.50%-20.92%+25.22% 130B
+0.36%-5.12%-55.76%-7.72% 67.64B
+0.29%+0.42%+11.51%+18.43% 51.85B
+0.66%-0.73%-16.25%-13.01% 50.91B
-2.44%-1.57%+29.61%+28.54% 44.46B
-1.56%+2.47%+40.75%+51.70% 41.39B
+1.94%+5.20%-14.76%+49.29% 34.01B
Average -0.60%+0.28%+12.36%+18.83% 83.91B
Weighted average by Cap. -0.39%-0.26%+8.36%+12.52%

Financials

2026 *2027 *
Net sales 4.62B 3.99B 3.74B 3.42B 6.43B 441B 6.46B 44.37B 17.32B 223B 17.36B 16.98B 740B 4.91B 4.24B 3.97B 3.63B 6.83B 468B 6.86B 47.12B 18.39B 237B 18.44B 18.04B 786B
Net income 760M 656M 615M 562M 1.06B 72.51B 1.06B 7.29B 2.85B 36.67B 2.85B 2.79B 122B 891M 769M 721M 659M 1.24B 84.99B 1.24B 8.55B 3.34B 42.98B 3.35B 3.27B 143B
Net Debt 246M 212M 199M 182M 342M 23.46B 344M 2.36B 921M 11.87B 924M 904M 39.37B -729M -629M -590M -539M -1.01B -69.52B -1.02B -6.99B -2.73B -35.16B -2.74B -2.68B -117B
Logo Illumina, Inc.
Illumina, Inc. specializes in DNA sequencing and array-based technologies, serving customers in research, clinical and applied markets. The Company's products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Its comprehensive line of products addresses the scale of experimentation and breadth of functional analysis to advance disease research, drug development, and the development of molecular tests. It also specializes in data-driven proteomics technology. Its products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training.
Employees
8,625
Date Price Change Volume
28/08/26 US$215.59 -5.31% 1,791,366
27/08/26 US$227.69 +1.27% 1,937,242
26/08/26 US$224.84 -0.07% 1,714,494
25/08/26 US$224.99 +0.79% 1,918,113
24/08/26 US$223.22 +1.74% 2,250,988
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
215.59USD
Average target price
198.89USD
Spread / Average Target
-7.74%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ILMN Stock